Department of Infectious Diseases and Legal Medicine-Section of Infectious Diseases (Ed 18) - University of Naples Federico II, I-80131 Naples, Italy.
BMC Infect Dis. 2010 Mar 6;10:49. doi: 10.1186/1471-2334-10-49.
Drug-Induced Hypersensitivity Syndrome (DIHS) is a severe and rare systemic reaction triggered by a drug (usually an antiepileptic drug). We present a case of DISH and we review studies on the clinical features and treatment of DIHS, and on its pathogenesis in which two elements (Herpesvirus infection and the drug) interact with the immune system to trigger such a syndrome that can lead to death in about 20% of cases.
We report the case of a 26-year old woman with fever, systemic maculopapular rash, lymphadenopathy, hepatitis and eosinophilic leukocytosis. She had been treated with antibiotics that gave no benefit. She was taking escitalopram and lamotrigine for a bipolar disease 30 days before fever onset. Because the patient's general condition deteriorated, betamethasone and acyclovir were started. This treatment resulted in a mild improvement of symptoms. Steroids were rapidly tapered and this was followed with a relapse of fever and a worsening of laboratory parameters. Human herpesvirus 6 (HHV-6) DNA was positive as shown by PCR. Drug-Induced Hypersensitivity Syndrome (DIHS) was diagnosed. Symptoms regressed on prednisone (at a dose of 50 mg/die) that was tapered very slowly. The patient recovered completely.
The search for rare causes of fever led to complete resolution of a very difficult case. As DIHS is a rare disease the most relevant issue is to suspect and include it in differential diagnosis of fevers of unknown origin. Once diagnosed, the therapy is easy (steroidal administration) and often successful. However our case strongly confirms that attention should be paid on the steroidal tapering that should be very slow to avoid a relapse.
药物诱导的超敏反应综合征(DIHS)是一种由药物(通常是抗癫痫药)引起的严重且罕见的全身反应。我们报告了一例 DIHS,并回顾了关于 DIHS 的临床特征和治疗以及发病机制的研究,在发病机制中,两个因素(疱疹病毒感染和药物)与免疫系统相互作用,引发这种综合征,约 20%的病例可导致死亡。
我们报告了一例 26 岁女性发热、全身斑丘疹、淋巴结病、肝炎和嗜酸性粒细胞增多症。她曾接受抗生素治疗,但无效果。发热前 30 天,她因双相障碍而服用艾司西酞普兰和拉莫三嗪。由于患者一般状况恶化,开始使用倍他米松和阿昔洛韦。治疗后症状略有改善。迅速减少类固醇剂量,随后发热复发,实验室参数恶化。聚合酶链反应(PCR)显示人类疱疹病毒 6(HHV-6)DNA 阳性。诊断为药物诱导的超敏反应综合征(DIHS)。泼尼松(剂量为 50mg/d)治疗后症状消退,且剂量逐渐减少。患者完全康复。
寻找发热的罕见病因导致了非常困难病例的完全缓解。由于 DIHS 是一种罕见疾病,最相关的问题是怀疑并将其纳入不明原因发热的鉴别诊断。一旦确诊,治疗简单(给予类固醇)且通常有效。然而,我们的病例强烈证实,应注意类固醇的逐渐减少,以避免复发。